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ABSTRACT 
Mefenamic acid (MFA) is used as an anti-inflammatory, antinociceptive, and antipyretic 
agent for treatment of a wide range of pathological disorders. While the uncertainty of its 
safety and the poor oral bioavailability constitute the major limiting factors of its medical use, 
considerable efforts including liposomal encapsulation are needed to achieve maximum 
therapeutic advantages. The current work was conducted to investigate the ultrastructural 
alterations in the liver induced by free MFA and its liposomal preparation. Female Sprague-
Dawley rats were treated with daily oral doses of either free MFA or MFA entrapped in 
Tween 80 inoculated liposomes at the concentration of 80 mg/kg for 28 days. Ultrathin 
sections were prepared from biopsies taken from the liver of each member of all animals 
under study and subjected to examination by transmission electron microscopy. The liver of 
rats that were exposed to liposomal MFA showed more ultrastructural alterations than the rats 
treated with the free drug. While both groups of rats demonstrated sinusoidal dilatation, 
Kupffer cell hyperplasia, mitochondrial damage, and nuclear alterations, rats treated with 
liposome-encapsulated MFA induced an increase in the multiple lysosomes formation, 
hepatocytic steatosis, and apoptotic activity than free MFA-treated rats. The ultrastructural 
findings of the present study indicate that the use of liposomal MFA induces more hepatic 
damage than the use of free MFA. 
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